Morning

Change the Delivery, Change the Day.®

Taking ownership of the Early Morning Routine for children with ADHD.

Our Products

DELEXIS® - Proprietary Drug Delivery Platform

Highland’s wholly owned subsidiary, Ironshore Pharmaceuticals & Development, has developed a novel oral, once-daily, drug delivery technology. DELEXIS® allows drugs to be dosed at night, targeting onset of action prior to awakening.

Learn More About DELEXIS®

Our Approach

Our Approach

Our lead products are targeted at helping ADHD patients and their families by leveraging proprietary technologies to address a significant unmet medical need – inadequate control of symptoms of ADHD during the morning routine.

Early Morning Functioning

Early Morning Functioning

A majority of surveyed families report ADHD symptoms as ‘severe’ or ‘moderate-to-severe’ during the morning routine – the period immediately upon waking until the patient leaves for work or school. This period is often the busiest and most chaotic for families.

Controlled Release

Controlled Release

Highland has developed a proprietary, oral controlled-release technology for evening dosing of medication with delayed and extended release characteristics that is designed to provide for next-day therapeutic activity beginning in the early morning and lasting throughout the day.

Press

Recent News